naproxen sodium
Commercial- Indications
- Pain
Company intelligence / Profile preview
Victory Pharma
San Diego, California, United Statesvictorypharma.com ↗
- Ownership
- Private
- Employees
- ~75
- Development stage
- Commercial
01
Overview
Victory Pharma was a pharmaceutical company focused on pain management products. Their lead product was NAPRELAN, a once-a-day controlled-release formulation of naproxen sodium, a non-steroidal anti-inflammatory drug (NSAID). The company was acquired by Shionogi in 2011 for $118 million.
- Therapeutic areas
- GastroenterologyNeurologyInfectious Diseases
- Modalities
- Small molecules
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Victory Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Victory Pharma.